Measuring urine salicylate levels is one way to evaluate treatment compliance among patients with ulcerative colitis who are taking mesalamine, according to a study published in The American Journal of Gastroenterology. Study author Dr. Alan Moss of the Center for Inflammatory Bowel Disease at Boston's Beth Israel Deaconess Medical Center said patient reports of compliance are not reliable. “The reality is that many patients skip doses or pills. We know from other studies that these patients are more likely to experience disease relapses," Moss said.
Published in Brief: